Which medication is commonly discussed for managing obesity in medically complicated patients?

Study for the HESI Maternity/Pediatric Test. Utilize flashcards and multiple-choice questions, each with hints and explanations. Prepare for your exam confidently!

Octreotide is commonly discussed for managing obesity in medically complicated patients because it functions as a somatostatin analogue, which can help regulate various hormonal pathways that influence metabolism and appetite. It primarily works by inhibiting the secretion of various hormones, including growth hormone, insulin, and glucagon, thus impacting glucose metabolism and fat storage. This can be particularly beneficial for patients with conditions like acromegaly or those who are attempting to manage weight while dealing with the complexities of other medical issues.

In the context of treating obesity, octreotide may help reduce appetite and promote weight loss, especially in patients who have conditions that contribute to obesity. It is often considered in situations where traditional weight loss methods are ineffective or when patients have obesity-related complications that require a more careful approach to weight management.

Other medications listed, such as morphine, ibuprofen, and venlafaxine, do not have a direct role in the management of obesity or the specific metabolic complications it may cause. Morphine is an opioid used primarily for pain management, ibuprofen is an anti-inflammatory medication, and venlafaxine is an antidepressant that can have side effects on appetite but is not specifically indicated for obesity management. Thus, octreotide stands out as the

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy